دورية أكاديمية

BRMS1 gene expression may be associated with clinico-pathological features of breast cancer.

التفاصيل البيبلوغرافية
العنوان: BRMS1 gene expression may be associated with clinico-pathological features of breast cancer.
المؤلفون: Lin LZ; Department of Oncology, Taizhou Central Hospital, Taizhou 318000, P.R. China., Cai MG; Department of Oncology, Luqiao Branch of Taizhou Hospital, Taizhou 318000, P.R. China., Dai YC; Department of Oncology, Taizhou Central Hospital, Taizhou 318000, P.R. China., Zheng ZB; Department of Oncology, Taizhou Central Hospital, Taizhou 318000, P.R. China., Jiang FF; Department of Oncology, Taizhou Central Hospital, Taizhou 318000, P.R. China., Shi LL; Department of Infection, Luqiao Branch of Taizhou Hospital, Taizhou 318000, P.R. China., Pan Y; Department of Oncology, Taizhou Central Hospital, Taizhou 318000, P.R. China yinpanypp@163.com., Song HB; Department of Infection, Luqiao Branch of Taizhou Hospital, Taizhou 318000, P.R. China.
المصدر: Bioscience reports [Biosci Rep] 2017 Aug 21; Vol. 37 (4). Date of Electronic Publication: 2017 Aug 21 (Print Publication: 2017).
نوع المنشور: Journal Article; Meta-Analysis
اللغة: English
بيانات الدورية: Publisher: Portland Press on behalf of the Biochemical Society Country of Publication: England NLM ID: 8102797 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1573-4935 (Electronic) Linking ISSN: 01448463 NLM ISO Abbreviation: Biosci Rep Subsets: MEDLINE
أسماء مطبوعة: Publication: London : Portland Press on behalf of the Biochemical Society
Original Publication: London : The Biochemical Society, c1981-
مواضيع طبية MeSH: Biomarkers, Tumor/*genetics , Breast Neoplasms/*genetics , Breast Neoplasms/*pathology , Lymph Nodes/*pathology , Repressor Proteins/*genetics, Case-Control Studies ; Confidence Intervals ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Lymphatic Metastasis ; Neoplasm Staging ; Odds Ratio ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Statistics as Topic
مستخلص: Our aim is to investigate whether or not the breast cancer metastasis suppressor 1 ( BRMS1 ) gene expression is directly linked to clinico-pathological features of breast cancer. Following a stringent inclusion and exclusion criteria, case-control studies with associations between BRMS1 and breast cancer were selected from articles obtained by way of searches conducted through an electronic database. All statistical analyses were performed with Stata 12.0 (Stata Corp, College Station, TX, U.S.A.). Ultimately, 1,263 patients with breast cancer were found in a meta-analysis retrieved from a total that included 12 studies. Results of our meta-analysis suggested that BRMS1 protein in breast cancer tissues was significantly lower in comparison with normal breast tissues (odds ratio, OR = 0.08, 95% confidence interval (CI) = 0.04-0.15). The BRMS1 protein in metastatic breast cancer tissue was decreased than from that was found in non-metastatic breast cancer tissue (OR = 0.20, 95%CI = 0.13-0.29), and BRMS1 protein in tumor-node-metastasis (TNM) stages 1 and 2 was found to be higher than TNM stages 3 and 4 (OR = 4.62, 95%CI = 2.77-7.70). BRMS1 protein in all three major types of breast cancer was lower than that of control tissues respectively. We also found strong correlations between BRMS1 mRNA levels and TNM stage and tumor size. The results our meta-analysis showed that reduction in BRMS1 expression level was linked directly to clinico-pathological features of breast cancer significantly; therefore, suggesting the loss of expression or reduced levels of BRMS1 is potentially a strong indicator of the metastatic capacity of breast cancer with poor prognosis.
(© 2017 The Author(s).)
References: Int J Biochem Cell Biol. 2010 Aug;42(8):1273-81. (PMID: 20026422)
Cancer Res. 2010 Dec 1;70(23 ):10002-11. (PMID: 21098703)
Tumour Biol. 2009;30(3):148-59. (PMID: 19609101)
Ann Epidemiol. 2012 May;22(5):340-8. (PMID: 22366170)
Stat Med. 2002 Jun 15;21(11):1539-58. (PMID: 12111919)
Genet Epidemiol. 2005 Feb;28(2):123-37. (PMID: 15593093)
Breast Cancer Res. 2012 Feb 07;14(1):R23. (PMID: 22314082)
Cancer Res. 2000 Jun 1;60(11):2764-9. (PMID: 10850410)
PLoS One. 2013;8(2):e55966. (PMID: 23390556)
Int J Cancer. 2012 May 15;130(10):2282-90. (PMID: 21671471)
Cancer Res. 2009 Dec 15;69(24):9498-506. (PMID: 19934330)
Int J Cancer. 2007 Mar 15;120(6):1169-78. (PMID: 17163420)
J Biol Chem. 2010 Jan 22;285(4):2750-7. (PMID: 19917603)
Cancer Metastasis Rev. 2010 Jun;29(2):285-93. (PMID: 20393783)
Tumour Biol. 2005 Jul-Aug;26(4):213-6. (PMID: 16006775)
J Clin Oncol. 2012 Feb 10;30(5):533-8. (PMID: 22231041)
Neoplasia. 2011 May;13(5):445-52. (PMID: 21532885)
Breast. 2011 Aug;20(4):309-13. (PMID: 20980149)
Eur J Gynaecol Oncol. 2014;35(3):236-42. (PMID: 24984534)
Oncotarget. 2014 Aug 30;5(16):7013-26. (PMID: 25026296)
Ann Oncol. 2012 Mar;23(3):618-24. (PMID: 21642515)
Anticancer Res. 2014 Mar;34(3):1417-26. (PMID: 24596389)
Cell Biochem Biophys. 2015 Jan;71(1):465-72. (PMID: 25182004)
FEBS Lett. 2011 Oct 20;585(20):3185-90. (PMID: 21827753)
J Natl Cancer Inst. 2013 Oct 16;105(20):1571-8. (PMID: 23985142)
Clin Exp Metastasis. 2009;26(2):89-96. (PMID: 18841483)
J Biol Chem. 2008 Oct 17;283(42):28354-60. (PMID: 18664570)
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 Oct;25(20):920-1. (PMID: 22239051)
Clin Cancer Res. 2006 Nov 15;12(22):6702-8. (PMID: 17121889)
Cancer Causes Control. 2012 May;23 (5):785-90. (PMID: 22438073)
J Thorac Dis. 2013 Jun;5 Suppl 1:S2-8. (PMID: 23819024)
Int J Mol Sci. 2012;13(9):11705-17. (PMID: 23109879)
Int Rev Cell Mol Biol. 2011;286:107-80. (PMID: 21199781)
Cancer Lett. 2009 Apr 18;276(2):196-203. (PMID: 19111386)
Clin Cancer Res. 2006 Nov 1;12(21):6410-4. (PMID: 17085653)
فهرسة مساهمة: Keywords: BRMS1; Breast cancer; Clinico-pathological features; Meta-analysis; Metastasis; Prognosis
المشرفين على المادة: 0 (BRMS1 protein, human)
0 (Biomarkers, Tumor)
0 (RNA, Messenger)
0 (Repressor Proteins)
تواريخ الأحداث: Date Created: 20170524 Date Completed: 20180608 Latest Revision: 20181113
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC5563535
DOI: 10.1042/BSR20170672
PMID: 28533425
قاعدة البيانات: MEDLINE
الوصف
تدمد:1573-4935
DOI:10.1042/BSR20170672